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Abstract
Intravenous norepinephrine (NE) is utilized commonly in critical care for cardiovas-
cular	support.	NE’s	impact	on	cerebrovasculature	is	unclear	and	may	carry	important	
implications during states of critical neurological illness. The aim of the study was 




cerebral vasculature was recorded, were included. We identified 62 animal studies 
and 26 human studies. Overall, there was a trend to a direct vasoconstriction effect 
of NE on the cerebral vasculature, with conflicting studies having demonstrated both 
increases and decreases in regional CBF (rCBF) or global CBF. Healthy animals and 
those	 undergoing	 cardiopulmonary	 resuscitation	 demonstrated	 a	 dose-dependent	
increase in CBF with NE administration. However, animal models and human patients 
with acquired brain injury had varied responses in CBF to NE administration. The ani-
mal models indicate an increase in cerebral vasoconstriction with NE administration 
through	the	alpha	receptors	in	vessels.	Global	and	rCBF	during	the	injection	of	NE	
displays a wide variation depending on treatment and model/patient.
K E Y W O R D S
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1  | INTRODUC TION
l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol	or	norepinephrine	(NE)	is	
an adrenergic drug that is used in a variety of medical care and treat-
ment. It has emerged as one of the most commonly utilized vasopres-
sor agents for general cardiovascular support in the management of 
critically ill patients, through modulation of adrenergic receptors.1,2 
Systemically,	NE	is	well	known	to	cause	vasoconstriction	and	in	high	
sustained	doses	it	may	lead	to	limb	or	end-organ	ischemia.3
Despite these concerns regarding systemic vasoconstriction related 
to NE, it is widely employed, including in those patients with critical neu-
rological illness, such as traumatic brain injury (TBI).4,5 However, it remains 
unclear if detrimental vasoconstrictive responses are seen in the cerebral 
vasculature	with	NE	 administration	 in	 human	 TBI	 patients.	 Given	 that	
many secondary injury mechanisms in the setting of TBI and other criti-
cal neurological illness, resulting in altered or reduced cerebral blood flow 
(CBF) or impaired cerebrovascular reactivity,6,7 understanding the impact 
of exogenously administered NE on cerebrovascular reactivity and CBF is 
crucial. Such understanding may impact our choice of vasopressor agent 
in	specific	neuropathologic	states.	Similarly,	knowledge	here	will	allow	us	
to anticipate potential cerebral physiologic responses related to NE, as we 
begin to transition to personalized physiologic targets, particularly in TBI 
care, based on cerebrovascular reactivity monitoring.8-13
Human studies evaluating vasopressors and cerebrovascular re-
sponse in critical neurological illness are inherently confounded by 
ongoing active treatments for intracranial pressure (ICP), cerebral per-
fusion	pressure	(CPP),	and	other	physiologic	metrics.	As	such,	focusing	
on past experimental studies may shed light on the overall impact of 
NE on cerebrovascular reactivity and CBF, providing a basic under-
standing of potential expected responses in humans. This will aid the 
design of future prospective human and large animal model studies on 
the impact of vasopressor agents on the cerebral vasculature.
The goal of this study was to perform a systematically conducted scop-
ing review of all available literature on the impact of NE on cerebrovascular 
responsiveness/CBF response, including animal and human studies.
2  | MATERIAL S AND METHODS
A	 systematic	 review	 of	 the	 available	 literature	 was	 conducted	
using	 the	 methodology	 outlined	 in	 the	 Cochrane	 Handbook	 for	





2.1 | Search question, population, and inclusion and 
exclusion criteria
The question posed for systematic review was: What is the effect 
of exogenous systemically administered NE on the cerebrovascular 
response/cerebral	blood	flow?	All	 studies,	prospective	and	retrospec-
tive, animal or human subject, of any size were included. The reason for 
an	all-inclusive	search	was	the	small	number	of	studies	of	any	type	iden-
tified	by	the	primary	author	during	a	preliminary	search	of	MEDLINE.
The primary outcome measure was the impact on CBF or the 
cerebrovascular responsiveness as documented by autoradio-
graphic diffusible tracer technique, electromagnetic flow probe, 
freely diffusible tracers, thermal diffusion probe, clearance method, 
laser-Doppler	 flow	 probe,	 radioactive	 gas	 elimination,	 radioactive	
microsphere, flow transducer and flow meter, visual recording soft-
ware, or any other objective means of CBF determination. Secondary 
outcomes included adverse effects of NE administration.
All	studies,	whether	prospective	or	retrospective,	of	all	sizes	or	
of any age category, and with the use of NE with formal documen-
tation of cerebrovascular response/CBF during administration were 






vidualized search strategies for each database. The search strategy for 
MEDLINE	can	be	seen	in	Appendix	B	of	the	Supplementary	Materials,	
with a similar search strategy used for the other databases. Finally, the 
reference lists of reviewed articles on the cerebral blood vessels/CBF 
response to NE were examined to ensure no references were left out.
2.3 | Study selection
Using	 two	 reviewers	 (LF	 and	 JD),	 a	 two-step	 review	of	 all	 articles	
returned by our search strategies was performed. First, the review-
ers independently screened all titles and abstracts of the returned 
articles to decide whether they met the inclusion criteria. Second, 
full text of the chosen articles was assessed to confirm whether they 
met the inclusion criteria and that the primary outcome of CBF/cer-
ebrovascular	 response	 to	NE	was	 documented.	Any	 discrepancies	
between	the	two	reviewers	were	resolved	by	a	third	party	(FAZ).
2.4 | Data collection
Data were extracted from the selected articles and stored in multi-
ple electronic databases to ensure data integrity.
2.5 | Animal studies
Data fields included the following: number of animals, type of 
study, animal model characteristics, the goal of the study, dose of 
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vasopressors administered, type of vasopressors administered, 
technique of CBF/vasculature assessment, ventilator parameters 
(including pCO2 and pO2—if documented), sedation regimen admin-
istered, CBF/cerebral vasculature response to NE, other outcomes 
and general conclusions.
2.6 | Human studies
Data fields included the following: number of patients, type of study, 
patient characteristics, the goal of the study, dose of vasopressors 
administered, type of vasopressors administered, technique of CBF/
vasculature assessment, ventilator parameters (including pCO2 and 
pO2—if documented), sedation regimen administered, CBF/cerebral 
vasculature response to NE, other outcomes and general conclusions.
2.7 | Bias assessment
Given	the	goal	of	this	review	was	to	provide	a	comprehensive	scop-
ing overview of the available preclinical literature, a formal bias as-
sessment was not conducted.
2.8 | Statistical analysis
A	meta-analysis	was	not	performed	in	this	study	because	of	the	het-
erogeneity of model types, study designs, and data.
3  | RESULTS
3.1 | Search results and study characteristics
The results of the search strategy across all databases and refer-
ence sections of articles are summarized in Figure 1. Overall, a total 
of	 2463	 articles	were	 identified,	 all	 from	 the	 databases	 searched.	
A	total	of	635	were	removed	because	of	duplication	of	references,	
leaving 1825 to review. By applying the inclusion/exclusion criteria 
to the title and abstract of these articles, we identified 288 articles 
that fit these criteria. Six articles were added from reference sec-
tions	of	pertinent	review	articles,	leaving	a	total	of	294	papers	to	re-
view.	The	portable	document	formats	(PDFs)	of	these	294	were	then	
gathered.	 Applying	 the	 inclusion/exclusion	 criteria	 to	 these	 PDFs,	
only 88 articles were found eligible for inclusion in the systematic 
review.	Articles	were	excluded	because	they	either:	did	not	report	
F I G U R E  1  PRISMA	flow	diagram
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details around the CBF/cerebrovascular response to NE administra-
tion or were nonrelevant. One article was a retrospective study fo-
cused	on	CBF	and	brain	function	during	hypotension	and	shock.16
3.2 | Animal models
Within the 62 animal studies identified, the majority of cases measured 
CBF response to NE and other agents, utilizing: autoradiographic dif-
fusible tracer technique, electromagnetic flow probe, freely diffusible 
tracers,	thermal	diffusion	probe,	clearance	method,	laser-Doppler	flow	
velocity, radioactive gas elimination, radioactive microsphere, flow 
transducer and flow meter, visual recording software, and two other 
methods. The animal models studied included baboons (3),17-19 cats 
(8),20-27 dogs (11),28-38 goats (3),39-41 pigs (12),42-53 sheep (1),54 mice 
(1),55 rabbits (5),56-60 rats (17)61-77 and one retrospective study16 with 
dogs, cats, rats, and humans. The characteristics of the animal studies 
can be seen in Tables 1 and 2. The majority of the models was heav-
ily anesthetized, with only two studies where the animals were lightly 
sedated40,42 and four studies where animals had no sedation or an-
esthetia.39,41,55,60	A	further	four	articles27,38,44,70 had NE injected with 
another vasoactive substance, seven articles20,23,27,52-54,70 where the 
models had craniotomy, five articles34,36,37,73,77 where models had ex-
planted brains for the evaluation of vessel response, four articles44-47 
where models were administered cardiopulmonary resuscitation 
(CPR) during NE injection, four articles48,50,51,74 where models had a 
TBI, three articles21,35,66 where some models had hypothermia, two 
articles41,56 where models had a superior cervical sympathetic gan-
glionectomy, one article where models had bile duct ligations,19 and 
one	article	where	models	had	induced	endotoxin	shock.43 Seventeen 
studies had NE administered at varying dose levels on healthy mod-
els.17,20,26,29,36,39,40,52-54,59,63-65,69,71,72 In 23 of the studies the par-
tial pressure of oxygen and carbon dioxide were either controlled 
through ventilation,21,25,29,31,35,43-49,51,53,56,57,60-62,66,70,71,73	 or	 taken	
to be constant throughout the study in 28.17-19,22-24,28,30,32-34,36-
39,50,52,54,55,58,59,63-65,68,72,74,75 Ten studies did not mention accounting 
for the pCO2 or pO2.
20,26,27,40-42,67,69,76,77
3.3 | NE impact on objectively measured CBF
The following subsections provide a narrative summary of the im-
pact of NE administration on objectively measured cerebrovascu-
lar	response/CBF,	looking	first	at	overall	increase/decrease	in	CBF,	
followed	by	measured	models	pathology-specific	responses	to	NE.	
Table S2 of the Supplementary Materials provides a detailed tabula-
tion of medication dosing, measurement technique, and results.
3.4 | Increase in CBF
Twenty-six	studies	demonstrated	an	increase	in	global	or	rCBF	with	
the administration of NE.17,18,23,25,36,38,40,41,45-50,62-65,67-72,75,76 The 
CBF increase ranged from not significant, to changes on the order 
of 500% of the initial CBF value.45 In studies which measured rCBF, 
all areas increased in blood flow except the auditory cortex65 and 
mesencephalon.62	 Six	 studies	 had	 a	 dose-dependent	 increase	 in	
CBF,40,45,46,70-72	with	one	study	showing	a	peak	CBF	at	a	NE	dose	of	
0.16	mg/kg.45 The variation within the data between the individual 
animal models and pathologies limits the ability to draw any clear 
conclusions within species or technique.
3.5 | Decrease in CBF
Twenty-two	 studies	 demonstrated	 a	 decrease	 in	 CBF	 or	 rCBF	 by	
the administration of NE.19,21,22,24,28-30,32-34,39,42-44,51,55,57,58,60,61,73,74 
The CBF decrease had a wide range in variation from not significant, 
to a max reduction of 70%.58 In the single study that both monitored 
rCBF and CBF, an overall decrease in rCBF was seen in all areas ex-
cept the brain stem.43
3.6 | Direct vascular response
Of the seven studies that evaluated direct cerebrovascular response 
to NE,20,26,27,52,53,59,77 all had some form of constriction to the cer-
ebral vessels. This cerebral vessel change ranged from nonsignifi-
cant up to 20% constriction as compared to baseline values.52,53,59 
However, models that had a significant constrictive response to 
NE were either injected with another solution (a hypertonic saline 




There	were	 29	 studies	 that	 used	 healthy	 fully	 anesthetized	mod-
els, without a craniotomy, and assessed CBF.17,18,22,24-26,29-33,49,57-
69,71,72,75,76 Five showed a nonsignificant response in CBF to NE 
administration.25,31,57,60,66 In the remaining studies there were 
conflicting responses seen, with NE leading to both increas-
ing17,18,22,25,33,62,64-69,71,72,75,76 and decreasing CBF.22,24,29-31,58,60,61,65 
Despite these conflicting responses, there were some study design 
specifics	to	take	note	of.
First, the influence of coadministered substances on the effects 
of NE demonstrated some findings of interest. Such substances in-
clude: hypertonic saline,18,62 phentolamine,24,33,59,61 phenoxyben-
zamine,32,64 and propranpol.31,32,49,62 Hypertonic saline injected with 
NE significantly increased CBF and cerebral metabolic rate of oxy-
gen consumption (CMRO2) as compared to NE alone.
18,62 Similarly, 
when	NE	was	 allowed	 to	 pass	 the	 blood-brain	 barrier	 (BBB)	 after	
osmotic opening with urea, an increased regional flow was ob-
tained.62 Phentolamine inhibited or completely mitigated the CBF 
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TA B L E  1   Included studies—general characteristics and study goals
Reference
Number of 
animals Study type Model characteristics Primary and secondary goals of study
Healthy heavily anesthetized animal models
McCalden et al, 
197917
15 baboons Three-arm	study Healthy baboons anesthetized with 
ketamine	hydrochloride	and	sodium	
pentobarbital
Primary: Role of catecholamine 
degradative enzymes and the adrenergic 
innervation in determining the 
cerebrovascular response to infused NE
MacKenzie	et	al,	
197618
18 baboons Two-arm	study Healthy baboons anesthetized with 
thiopentone sodium, phencyclidine, 
and suxamethonium
Primary: Test the effects of NE on 
cerebrovascular activity
Secondary: Effect of hypertonic urea




Four-arm	study Healthy cats were anesthetized with 
pentobarbital sodium
Primary: Choroidal blood flow and the 
effects of autonomic agents
Muravchick	et	al,	
197621
26 cats Eight-arm	study Healthy mongrel cats anesthetized 
with pentobarbital
Primary:	Adrenergic	receptors	and	
vascular resistance in cerebral circulation






Healthy cats intraperitoneally 
anesthetized with sodium 
pentobarbital with vessel change 
measured in removed brains
Primary: Cerebrovascular reactivity to NE 
and serotonin following experimental 
subarachnoid hemorrhage
Tomita	et	al,	197923 23 cats Four-arm	study Healthy and cranial hypertensive 
cats anesthetized with urethane 
and chloralose
Primary: Distensibility of cerebral vessels 
in response to acute hypertension
Secondary: Blood pressure response to 
NE and papaverine
Haggendal et al, 
196628
11 dogs Three-arm	study Healthy mongrel dogs anaesthetized 
with pentobarbital
Primary: Effects of some vasoactive drugs 
on the vessels of cerebral grey matter in 
the dog
Secondary: In a few dogs, similar 
procedures were performed under the 








Healthy dogs that were bleed 
anesthetized with nitrous oxide and 
oxygen
Primary: Effect of NE on rCBF depending 
on	initial	MAP
MacDonnell et al, 
197130
4	dogs Three-arm	study Healthy mongrel dogs anesthetized 
with sodium pentobarbitonal
Primary: Factors affecting response of 
CBF and cerebral metabolism to NE 
infusion
James	et	al,	197531 37 dogs Seven-arm	study Healthy mongrel dogs were 
anaesthetized with sodium 
pentobarbitonal
Primary: Evaluate factors affecting the 




21 dogs Two-arm	study Healthy mongrel dogs anaesthetized 
with thiopental and nitrous oxide
Primary: Effects of NE on CBF in dogs
Secondary:	Effect	of	alpha-adrenergic	
blockers	on	NE	and	CBF
Rogers	et	al,	198942 21 pigs Four-arm	study Healthy piglets anesthetized with 
halothane and with right common 
carotid artery ligated
Primary:	Influence	of	intra-arterial	NE	on	





Healthy rabbits—some anesthetized Primary: Possible mediation of CBF 
response to systemic NE
Patel	et	al,	199057 Not 
mentioned
Three-arm	study Healthy rabbits anesthetized with 
1.0	MAC	isoflurane




22 rabbits Two-arm	study Renal hypertension in healthy 
rabbits
Primary: Effect of high blood pressure on 
CBF in renal hypertension
(Continues)
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Reference
Number of 
animals Study type Model characteristics Primary and secondary goals of study
Tomomatsu et al, 
198159
62 rabbits Two-arm	study Healthy rabbits of either sex 
anesthetized with urethane
Primary: Increased activity of carotid 
sinus baroreceptors by sympathetic 
stimulation and NE
Edvinsson et al, 
197961
49	rats Six-arm	study Healthy	adult	male	Sprague-Dawley	
rats anesthetized with halothane
Primary: Quantitative changes in rCBF 
of	rats	induced	by	alpha	and	beta-
adrenergic stimulants




Primary: Effect of exogenous NE on local 
CBF	after	osmotic	opening	of	the	blood-
brain barrier in the rat
Lasbennes	et	al,	
198863
52 rats Three-arm	study Healthy male Wistar rats 
anesthetized with halothane
Primary: Effect of monoamine oxidase 
inhibition on rCBF
Secondary: Effect of clorgyline on 
cerebral hemodynamics
Szabo	et	al,	198364 59	rats Four-arm	study Healthy male rats anesthetized 
with pentobarbital sodium and 
immobilized with gallamine 
triethiodide




Tuor	et	al,	198665 16 rats Two-arm	study Healthy male rats anesthetized with 
halothane
Primary: Effect of hypertensive agent on 
regional cerebral perfusion
Nemoto et al, 
199666
13 rats Two-arm	study Healthy male Wistar rats 
anesthetized with halothane, some 
given donor blood and induced mild 
hypothermia
Primary: NE activation of basal cerebral 










Primary: To investigate the role of 
the endothelin system in pressure 
autoregulation of CBF in rats









Zhang	et	al,	199170 16 rats Three-arm	study Healthy	male	Sprague-Dawley	rats	
anesthetized with inactin
Primary: Superoxide dismutase decreases 
mortality, blood pressure, and CBF 
responses
Gozzi	et	al,	200771 35 rats Four-arm	study Healthy	male	Sprague-Dawley	rats	
anesthetized with halothane and 
nitrous oxide
Primary: Cerebral hemodynamics and 
autoregulation in pharmacological MRI




17 rats Three-arm	study Healthy male Dawley rats 
anesthetized with halothane with 
final values attend from removed 
brain
Primary: The effects of intravenous NE 
on the local coupling between glucose 
utilization and blood flow in the rat brain
Kraut	et	al,	200473 9	rats Three-arm	study Healthy male Wistar rats 
anesthetized with equithesin
Primary: The effect of NE on tissue areas
Healthy	Lightly	Anesthetized	Animal	Models
Artru	et	al,	198133 18 dogs Four-arm	study Unmedicated fasting mongrel dogs 
with succinylcholine infusion 
followed by endotracheal 
intubation (anesthetized with 
nitrous oxide, halothane, 
pentobarbital,	or	ketamine)
Primary:	Anesthetics	affect	the	cerebral	
metabolic response to circulatory 
catecholamines
TA B L E  1   (Continued)
(Continues)
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Reference
Number of 
animals Study type Model characteristics Primary and secondary goals of study
Lluch	et	al,	197339 15 goats Five-arm	study Unanesthetized healthy female 
goats with thrombosis
Primary: Evidence for effects of 
adrenergic drugs on CVR
Secondary: The effect of amines on CBF
Perales	et	al,	199740 14	goats Three-arm	study Conscious female goats sedated 
with	ketamine
Primary: Effects of magnesium sulfate on 
the	NE-induced	cerebral	vasoconstrictor	
and pressor responses in the goat




Three-arm	study Healthy dogs lightly anesthetized Primary: Effects of dopamine, NE, and 
5-hydroxytryptamine	on	the	CBF	in	the	
dog
Secondary: The effect of dopamine in the 
presence of pimozide or haloperidol
Edvinsson et al, 
197255
124	mice Two-arm	study Unanesthetized sympathectomy 
male albino mice
Primary: Sympathetic neural influence on 




11 goats Two-arm	study Unanesthetized female goats with 
removed cervical ganglion
Primary: Effect of blood flow after 
removal of cervical ganglion
Secondary: The effect of NE, tyramine, 
phentolamine, and propranolol on CBF
Aubineau	et	al,	
198560
7 rabbits Three-arm	study Ganglionectomy	on	
rabbit anesthetized by 
diazepam-pentobarbital
Primary:	Long-term	effects	of	superior	
cervical ganglionectomy on cortical 
blood flow of nonanesthetized rabbits in 
resting and hypertensive conditions
Secondary:	Effect	of	NE	and	Angiotensin	
II on blood flow
Animal	models	with	bile	duct	removed
Bloom	et	al,	197519 16 baboons Nonrandomized 
control study
Bile duct removed in baboon 
anesthetized	with	ketamine	
hydrochloride and portion of them 
had their bile duct removed
Primary: Modification of the 
cerebrovascular response to NE by bile 
duct ligation
Healthy heavily anesthetized animal models with craniotomy
Shalit	et	al,	197424 32 cats Nonrandomized 
control study
Craniotomy on healthy adult cats 
anesthetized with pentobarbital 
with	balloon-induced	hypertension
Primary: Interrelationship between blood 
pressure and rCBF in experimental 
intracranial hypertension
Ulrich	et	al,	198525 21 cats Four-arm	study Craniotomy on adult cats 
immobilized with pancuronium 
bromide and anesthetized with 
glucochoralose
Primary:	In	vivo	effects	of	alpha-
adrenoceptor agonists and antagonists 
on pial veins of cats
Wei	et	al,	197526 47	cats Six-arm	study Craniotomy on anesthetized cats 
with sodium pentobarbital or 
urethane
Primary: Determinants of response of pial 
arteries to NE and sympathetic nerve 
stimulation
Busija	et	al,	198744 16 pigs Prospective 
randomized 
animal study




Primary: Eicosanoid synthesis elicited by 
NE in piglet parietal cortex
Secondary: NE and Isoproterenol effect 
on cerebral vessels
Leffler	et	al,	198945 19	piglets Prospective 
randomized 
animal study
Craniotomy on piglets anesthetized 
with	ketamine	hydrochloride	and	
acepromazine
Primary: Postischemic cerebral 
microvascular responses to NE and 
hypotension in newborn pigs
Myburgh et al, 
199854
5 sheep Three-arm	study Craniotomy on female sheep, 
anesthetized
Primary: Comparison of the effect of NE, 
E, and Dopamine on CBF and COU
Muir	et	al,	199374 17 rats Nonrandomized 
control study
Craniotomy on male Sprague 
rats anesthetized with sodium 
pentobarbital
Primary: Cocaine effect on blood pressure 
and CoBF (cortical) response to NE in 
rats
TA B L E  1   (Continued)
(Continues)
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Reference
Number of 
animals Study type Model characteristics Primary and secondary goals of study
Healthy heavily anesthetized animal models with explanted brains
Oberdorster et al, 
197334
14	dogs Three-arm	study Dissected canine brains anesthesia 
with a mixture of allobarbital, 
urethane, and ethylene urea, 
coagulation prevented with vetren
Primary:	Direct	effects	of	alpha	and	beta-
sympathomimetic amines on the cerebral 
circulation of the dog
Lowe	et	al,	197135 12 dogs Four-arm	study Brains from mongrel dogs 
premedicated with
morphine sulfate and anesthetic 
with methoxyflurane





6 dogs Three-arm	study Isolated perfused dogs brains which 
were intravenously anesthetized 
with a mixture of amobarbital and 
urethane
Primary: The effect of catecholamine on 
CBF and oxygen consumption in isolated 
perfused dog's brain





Brains of Wistar rats juvenile, 
mature, and old
Primary:	Age-related	changes	in	the	
sympathetic innervation of cerebral 
vessels and in carotid vascular responses 




7 rats Two-arm	study Brains from male Wistar rats 
anesthetized with pentobarbital 
sodium
Primary: The vasoconstrictive action of 
NE and serotonin in deep arterioles in rat 
cerebral gray matter
Various animal models
Mori	et	al,	199927 34	cats Three-arm	study Hypothermia induced in adult cats 
of both sexes anesthetized with 
halothane and continuous infusion 
of	ketamine	and	pancuronium	
bromide
Primary: Misery perfusion caused by 
cerebral hypothermia
Secondary: Effects of vasopressor 
administration on misery perfusion
Panther et al, 
198537
8 dogs Three-arm	study Brain cancer dogs anesthetized with 
sodium pentobarbital
Primary: Vasoactive drugs produce 
selective changes to blood flow
Nakagawa	et	al,	
197738
21 dogs Nonrandomized 
control study
Stereotaxic lesions made on 
hypothermic dogs anesthetized 
with thiamylal sodium and lesion
Primary: Role of posterior hypothalamus 
in the development of acute brain 
swelling
Secondary:	Lesion	effect	on	ICP
Miller	et	al,	198446 17 pigs Three-arm	study Endotoxin	shock	induced	in	healthy	
pigs	anesthetized	with	ketamine	
and pentobarbital
Primary: Vasopressors do not increase 
cerebral cortical blood flow in endotoxin 
shock
Anesthetized	animal	models	given	CPR





CPR in domestic pigs anesthetized 
with pentobarbital
Primary: Effects of combined 
administration of vasopressin, E, and NE 




14	piglets Two-arm	study CPR on pigs anesthetized with 
halothane	and	alpha-chloralose
Primary: The effect of NE vs E on CBF and 
myocardial blood flow during CPR
Brown	et	al,	198949 5 pigs Three-arm	study CPR on pigs anesthetized with 
halothane
Primary: The effect of NE vs E on rCBF 
during CPR
Secondary: CBF effect of NE and E in the 
presence of adrenergic antagonist
Lindner	et	al,	
199050
21 pigs Three-arm	study CPR on pigs anesthetized with 
metomidate and buprenorphine
Primary: The effects of E and NE 
on cerebral oxygen delivery and 
consumption	during	open-chest	CPR
Secondary: The effects of E and NE on 
CBF	during	open-chest	CPR
TA B L E  1   (Continued)
(Continues)
     |  9 of 49FROESE Et al.
effects of NE.24,33,59,61	 Likewise,	 phenoxybenzamine32,64 injected 
with NE demonstrated that the CBF and CMRO2 effects of NE were 
decreased.32,64 Propranolol demonstrated a decrease to CBF, when 
this was followed by an injection of NE CBF then increased.31,32,49,62
One	 study	 testing	 endothelin-1	 compared	 hypertension	 with/
without	endothelin-1.	NE	was	used	to	induce	this	hypertension	which	
caused a slight increase in CBF, with a significant CPP increase in 
controls.	Where	NE	 and	 endothelin-1	 caused	 the	 CBF	 and	CPP	 to	
both increase significantly.68 NE with or without experimental renal 
hypertension	had	a	similar	drop	 in	CBF	from	100	to	38	mL/100	g/
min. However during renal hypotension with blood loss, there 
was an increase in CBF followed by a return to low levels of CBF.58 
Furthermore, a cerebral vascular resistance (CVR) increase was seen 
during induced hypotension (bleeding) models with NE administra-
tion	(mean	arterial	blood	pressure	(MABP)	of	151	mmHg	in	controls	vs	
MABP	of	113	mmHg	in	the	hypotension	group),	which	caused	a	slight	
decrease in CBF by 10%.30	An	increase	in	CVR	was	a	universal	result	
in all the studies that evaluated CVR in healthy models.22,24,30,64
3.7.2 | Models with craniotomy or explanted brains
In the seven studies20,23,27,52-54,70 that had an in vivo craniotomy, 
or five studies34,36,37,73,77 with explanted brains (to analyze cerebral 
vessel response), the majority of them measured cerebral vessel di-
ameter	or	contraction	response	directly.	All	models	demonstrated	
that NE either caused a constriction of cerebral vessels,27,52,53,70,77 
or rarely they remained unaffected.20 In line with this, when 
CVR was measured there was an increase in CVR in response to 
NE,34,36,37 with varied response in CBF.
Using an extradural balloon to modulate ICP, one study indi-
cated that NE had no CBF effect if the ICP was above 70 mmHg, 
otherwise	there	was	a	direct	short-term	increase	to	CBF.23	Another	
study	observed	 the	pressure-flow	 relationship	 (measured	using	 a	
photoelectric drop recorder) in the brain for 30 minutes after the 
application	 of	 catecholamines.	 Based	 on	 the	 pressure-flow	 rela-
tionship tested in each brain, the indirect effects of catecholamines 
on CVR caused by autoregulatory influences were calculated. This 
calculation was determined mathematically and then accounted for 
in subsequent physiological experiments, which enable the study 
to focus purely on the catecholamine effects in the absence of au-
toregulatory	 influences.	After	the	autoregulatory	 influences	were	
removed, NE was seen to decrease CVR by 50% and demonstrate a 
slight decrease in CBF.34
Finally, in one study, the constriction of large arterioles was in-
duced through NE, with pial vessels remaining unchanged.20 While 
in	 rats,	 the	carotid	blood	flow	was	decreased	by	0.5	mL/min	 in	all	
ages of animals with the injection of NE. This study also found the 
Reference
Number of 
animals Study type Model characteristics Primary and secondary goals of study
TBI anesthetized animal models
Armstead	et	al,	
201651
40	pigs Three-arm	study TBI juvenile pigs anesthetized 
with fentanyl, midazolam, 
dexmedetomidine, and propofol
Primary:	NE’s	cerebral	autoregulation	
effects TBI in juvenile pigs
Secondary: How NE protects cerebral 
autoregulation
Friess et al, 201252 16 piglets Three-arm	
studies
TBI	4-week-old	piglets	anesthetized	
with fentanyl and isoflurane
Primary: PE vs NE after noninvasive brain 
trauma
Secondary: The effects of PE and NE in 
the young
Daley	et	al	200453 6 piglets Prospective-
randomized 
animal study





Ract et al, 200177 14	rats Three-arm	study TBI	in	Sprague-Dawley	rats	
anesthetized with pentobarbital








Dogs, cats, rats, and humans Primary: CBF and brain function during 
hypotension	and	shock
Abbreviations:	AT,	Angiotensin	II;	CBF,	cerebral	blood	flow;	CBV,	cerebral	blood	volume;	ChBF,	choroidal	blood	flow;	CMOT,	Catechol-O-
methyltransferase; CMRGluc,	cerebral	glucose	uptake;	CMRO2, cerebral oxygen consumption; CoBF, corticoid blood flow; COU, cerebral oxygen 





MVo,	myocardial	oxygen	consumption;	NE,	norepinephrine;	PE,	phenylephrine;	PGE2,	Prostaglandin	E2;	PO2, partial pressure of oxygen; rCBF, 
regional	cerebral	blood	flow;	SAH,	subarachnoid	hemorrhage;	TBI,	traumatic	brain	injury;	TXB2,	Thromboxane	B2;	5-HT,	5-hydroxytryptamine;
TA B L E  1   (Continued)










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.7.3 | Models given cardiopulmonary resuscitation
There were four studies in pigs that evaluated CBF while CPR was 
administered.44-47 During CPR, NE was given in two studies at 
varying	doses,	 resulting	 in	a	dose-dependent	 increase	 to	CBF.45,46 
Furthermore, increases in CMRO2 and CPP were also shown with 
the injection of NE.47	One	of	these	studies	had	NE	co-injected	with	
epinephrine and vasopressin, resulting in a more apparent increase 
in CBF, than compared to epinephrine or the vasopressin alone.44 In 
all of these studies, CBF increased with NE in comparison to control 
animals where NE was not given, with the NE effect on CBF ob-
served to dissipate after 5 minutes.44,47
3.7.4 | Models with traumatic brain injuries
In the four studies that had head trauma models, three of them used 
pigs48,50,51 and one used rats.74 In general, TBI caused a decrease in 
CBF, after the injury NE was given which caused an increase in CBF 
back	to	near	baseline	 levels.50,51,74 The partial pressure of oxygen 
was also increased in the one study that monitored blood gases.50 
One	 study	 compared	 the	CBF	 effects	 of	NE	 in	 brain-injured	 pig-
lets (fluid percussion injury) vs uninjured pigs. This study showed 
minor changes in CBF by NE in the uninjured pigs, but a significant 
increase in CBF by NE in the injuried.51 In the study with rat TBI 
models, NE administration led to an increase in ICP for 30 minutes, 
with a gradual decrease in CPP and slight decrease in CBF.74
3.7.5 | Other studied pathologies
There were some “other” pathologic states studied, including those 
with sympathectomy,55 induced intercranial hypertension, 23,25,58 
induced hypothermia,21,35,66 brain tumors, stereotaxic induced le-
sions,35	and	endotoxic	shock.43 In the studies that had models with 
removed ganglion41,56 or sympathetomy,55 there was a nonsignifi-
cant change tin CBF. However in models with ligated bile ducts NE 
both decreased CBF and increased CVR as compared to NE alone.19 
Whereas, in dogs with a brain tumor (induced by avian sarcoma 
virus) NE decreased CBF in both hemispheres (one with tumor/one 
without) and a subsequent decrease in partial pressure of oxygen.28 
In models with stereotaxic lesions (made in the posterior hypothal-
amus, unilaterally or bilateral)35	or	endotoxishock43 there was lim-
ited change in CBF or practical pressure of oxygen.35 Finally, when 
NE was given in induced intracranial hypertensive states, there 
were massive increases in CBF with each dose of NE.23,25,58
3.7.6 | Anesthesia in models
In the identified literature there were six studies where the animal 
model was not fully anesthetized.38-42,55,60 Within these studies 
there	was	a	dose-dependent	change	CBF	seen	in	these	models40,41 
and a constrictive force seen by NE injection.40 However no uni-
form results based on anesthetic regimen were documented. In 
the healthy anesthesia group, pentobarbital was used in 17 stud-
ies,17,20,22-24,26,28,29,31,32,43,44,56,64,70,74,77	ketamine	used	in	10	stud-
ies,17,19,21,38,40,43,51-53,69 as well as a variety of other substances. 
All	displayed	diverse	effects	of	NE	on	CBF	and	CMRO2, with no 
clear trend toward a specific effect. Though for the 13 studies that 
used halothane,21,38,45,46,49,61-63,65,66,68,72,75 either a nonsignificant 
change or an increase in CBF was seen. To note, in the studies 
that had a CBF increase due to NE, NE was either given in large 
amounts	 (over	 0.12	 mg/kg),45,46,63,72 with hypertonic urea62 or 
with	endothelin-1.68
3.8 | Human patients
Of the remaining studies, CBF was measured with nitrous oxide,95 
Kety-Schmidt	 technique,96-98 gas inhaliation,99,100 positron emis-
sion tomography,101 or the CMRO2/AVDO2 method (as previously 
stated).102	All	 failed	 to	document	a	significant	CBF	response	to	NE	
administration. However, in those studies assessing CVR, as measure 
through	the	comparison	of	CBF	to	MAP/CPP,	there	was	a	universal	
increase in CVR seen.80,84,87,89,93,95,97,98
Despite the multiple human studies with both healthy pa-
tients78-83,98 and patients with TBI,86-88,100-102 CBF in most patients 
remained	 relativity	unchanged.	Thus,	no	pathology-specific	 trends	
could be found in the human studies. There were three studies that 
had a nonsignificant decrease in CBF,86,98,100 and one with a nonsig-
nificant increase in CBF,102 indicating a wide range of CBF response 
to NE. In the one study that evaluated CBF in patients with cardiac 
arrest	 through	 the	MCAv,	 the	 flow	 velocity	 increased	 from	 27	 to	
33 cm/s.94 Of the remaining studies no clear trends were demon-
strated in the associate of NE to CBF.
3.9 | Adverse events
No human studies document the adverse effect to NE but three 
animal studies included adverse events.43,64,71 Two studies reported 
lethal doses of NE administration.64,71 In one study, the cause of 
death was determined to be the inhibition of autoregulation by NE.64 
This study also reported that continuous moderate doses of NE for 
longer than 2 hours prevented autoregulation measured through au-
toradiography.64 In TBI models, there appeared to be a trend toward 
vasoconstriction and varying global and rCBF reductions with NE 
administration.
     |  43 of 49FROESE Et al.
4  | DISCUSSION
NE	is	commonly	used	to	treat	life-threatening	low	blood	pressure	situ-
ations for its direct vascular effects.2 The scattered literature on the 
cerebrovascular effects of NE has produced studies displaying both a 
reduction and an increase in CBF, leaving a confusing picture on the 
exact cerebrovascular effects of the drug. The goal of this study was 
to provide a comprehensive systematically conducted scoping review 
of	 animal	 studies	 on	 NE’s	 effect	 on	 the	 cerebrovascular	 response/
CBF. Through our review we identified 62 animal studies16-77 and 26 
human studies78-103 pertaining to the cerebrovascular/CBF effects of 
NE. Within the 62 animal studies, a variety of different models were 
used,	with	the	majority	focusing	on	changes	in	global	CBF	or	rCBF.	A	
minority of studies focused on the direct effects of NE on the cerebral 
vasculature.26,27,37,52,53,59,77 Overall, regardless of the model or modal-
ity of measurement, NE led to a vasoconstrictive effect in medium cer-
ebral	 vessels	 in	 a	dose-dependent	manner,	with	no	clear	directional	
change to either global CBF or rCBF. Pial vessels seemed to remain 
unaffected. However, significant heterogeneity in study design, mod-
els, and outcome assessment limits the degree to which these results 
can be interpreted and translated to clinical practice. Some important 
points can be gleaned from this review.
First, NE administration in animals leads to a vasoconstriction 
of medium cerebral vessels.26,27,37,52,53,59,77 This is in the setting 
of constant pCO2 and pO2 during the experiments. The literature 
demonstrating an effect on pial vasculature was limited, with only 
one study which demonstrated no change to their diameter.53 
Furthermore this constrictive effect was shown to be inhibited 
by	 alpha	 adrenergic	 blockers	 like	 phenoxybenzamine	 and	 phen-
tolamine in animal models,26,32,33,37,39,41,59,61,64 and in one human 
study.80	Given	the	relative	homogeneity	of	the	studies	on	NE	va-
soconstrictive traits and the inhibition by alpha adrenergic drugs, 
it can be inferred that NE stimulates alpha receptors to contract 
vessel	within	 the	 brain,	 similar	 to	NE’s	 effect	 on	 other	 systemic	
vessels. This general feature, found across different species of an-
imal models, different model types from healthy to injured, and 
different sedation regimens, carries important implications for the 
application of the agent in humans with critical neurological ill-
ness. Direct cerebral vasoconstriction from NE may expose the 
brain to wider derangements in cerebral autoregulation/cerebro-
vascular reactivity, and lead to episodes of hyperemia or ischemia. 
Further to this, if NE administration were to abolish or eliminate 
cerebral autoregulatory capacity altogether, as seen on some of 
the animal studies identified, this could lead to catastrophic con-
sequences.43,64,71 These consequences are particularly important 
in	TBI	patients,	where	it	is	well	known	that	impaired	cerebrovas-
cular reactivity is strongly associated with outcome,6,104-106 and 
is present in many patients during their ICU stay and remains 
refractory to treatment effects.105,107 It also carries implications 
for the use of vasopressor agents in the targeting of individual-
ized physiologic targets in TBI based on continuous cerebrovas-
cular reactivity monitoring.8-13	Though,	it	must	be	acknowledged,	
these results from animal models and one human study may not 
translate directly to all humans and requires future investigation 
in both large animals and humans with TBI.
Second, the data are not clear regarding the change in global 
and rCBF with the injection of NE and why there appears to be such 
a discrepancy of response between studies and models. In healthy 
and	CPR	animal	models,	 there	was	a	 trend	toward	a	dose-depen-
dent increase in CBF. However, in TBI and other cerebral lesion 
models, the impact of NE on CBF was heterogeneous, in the set-
ting of constant/controlled pCO2 and pO2. Sedation regimen did 
not seem to impact these findings based on the available data in 
the parent manuscripts. In such acquired brain injury models, it 
is possible that the CBF reductions seen can be more directly as-
sociated with the alterations in CBV, and thus ICP, occurring with 
NE-based	cerebral	vasoconstriction,	as	opposed	to	any	direct	flow	
augmenting effect of NE. However, in some studies that measured 
CBV and CBF, the data demonstrated a positive linear connection 
between them during NE administration.22,25,55,72 Furthermore, 
such acquired brain injury states may lead to regional disparities 
in	 blood-brain	 barrier	 (BBB)	 functionality.	Areas	 of	 impaired	BBB	
integrity may lead to more extracellular deposition of NE, leading to 
direct	action	on	both	the	vasculature	and	cellular	support	network,	
causing variability in CBF response seen. Such BBB impacts on NE 
effects may be important, as healthy data suggest that an intact 
healthy barrier prevents much of the systemic catecholamines from 
entering the extracellular space. Further investigation is required 
into the regional disparities of CBF secondary to NE in the context 
of acquired brain injury.
Furthermore, the injection of NE through systemic routes may 
have effects different than NE directly injected within the brain. 
NE injected with hypertonic urea or MgSO4 solution resulted in 
an	increase	in	CBF	with	the	same	dose	of	NE.	As	such	it	 is	 likely	
that the BBB mediates the perfusion of NE throughout the brain 
and its effects on CBF.18,40,62 This point may also by enforced by 
the fact that during studies where animals had lesions that opened 
the BBB, an increase in CBF after NE injection was seen.40	Also	
in studies with impaired autoregulation there was a consistent 
response to NE with an increase in ICP and CBF.23,24	 All	 these	
findings support a potential role for the BBB in the regulation on 
cerebrovascular	response	to	NE.	As	mentioned	above,	in	line	with	
this, NE given systemically may not enter the brain parenchyma 
due to the BBB, though it is clear that the BBB limits the perme-
ation of NE it may not prevent all of the NE from entering the 
BBB.18,108	This	particular	area	of	BBB	integrity,	its	impact	on	NE-
based cerebrovascular/CBF responses in acquired brain injury, is 
an area requiring much further investigation.
Third, six studies demonstrated that the exogenous admin-
istration of NE reaches a maximal effect on cerebrovascular re-
sponse.20,29,31,32,45,71	 All	 of	 these	 studies	 compared	 various	 doses	
of NE which resulted in a maximum change in both CBF and CVR 
of	the	animal	models.	Thus,	a	dose-dependent	response	to	NE	oc-
curs, which again carries important implications for continuous cere-
brovascular reactivity monitoring and derivation of individualized 
physiologic target in TBI. However, a universal max dose of NE, in 
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terms of CVR effect, could not be demonstrated due to the hetero-
geneity	within	the	studies,	and	is	unlikely	to	exist	in	vivo	in	humans.	
NE-dosing	 thresholds	and	 their	 impact	on	continuously	monitored	
cerebrovascular reactivity/CBF in vivo in critically ill neurological 
patients, such as the TBI population, have not been conducted, and 
require further investigation.
Finally, unwanted cerebral physiologic side effects of NE ad-
ministration	were	seen.	Demonstration	of	NE’s	impact	on	ICP	was	
shown by using an extradural balloon to increase ICP. NE had no 
effect on the overall ICP, unless ICP was at the extreme pressure 
of over 70 mmHg.23 Furthermore in studies that measure CBV and 
CBF, the data demonstrated a positive linear connection between 
them.21,25,55,72 This linear connection encourages the idea that po-
tentially the change in CBF has more to do with alterations in CBV 
than the CVR effect of NE. The inhibition of autoregulatory hemo-
dynamics within the brain by NE injections was also described.64 
Prolonged or long continuous injections have resulted in lethal 
inhibition to cerebral hemodynamics, as highlighted in two stud-
ies.64,71	As	mentioned	above,	regarding	individualized	physiologic	
targets	in	TBI	care,	this	aspect	of	prolonged	high-dose	NE	adminis-
tration needs to be considered and investigated further.
4.1 | Limitations
In this review we have been able to systematically, and compre-
hensively, document the current literature on the cerebrovascular/
CBF effects of NE. There is a trend in the animal literature of a 
vasoconstriction of cerebral vessels seen with NE administration, 
with conflicting results regarding global and rCBF responses, de-
pending on the presence of acquired brain injury. However, caution 
must	be	taken	as	our	review	has	several	limitations.	The	studies	are	
quite heterogenous in design and species, with mixed results. The 
animal	studies,	given	heterogeneity	and	potential	 species-specific	
responses, limits our ability to translate these results to the clinical 
application of NE in humans regardless of the underlying pathology. 
Furthermore most human studies measured CBF through an as-
sumption	of	MCAv,	this	is	not	a	true	measure	of	global	CBF	or	rCBF.	
Another	 limitation	 is	 the	 lack	of	blood	gas	control	 in	some	of	 the	
studies. Cerebrovascular/CBF physiologic response is intimately 
linked	to	pCO2 and pO2 status, therefore due to the large number 
of studies that did not fully account for fluctuations in the blood gas 
level,	leaves	any	conclusion	linked	with	NE	deficient.	Last,	although	
there are trends in the animal models, there is still a significant limi-
tation to apply them in clinical practices simply based on the limited 
number of effect human studies.
4.2 | Future directions
Further prospective studies on the cerebrovascular/CBF ef-
fects of NE in the neurologically ill patient population need to 
be performed to determine the role of this medication within 
neuroanesthesia	 and	 the	 neuro-ICU.	 The	 potential	 CBF	 trends	
seen with NE are interesting and carry important implications 
in the treatment of a variety of cerebral pathologies, with TBI 
mentioned as exemplar given that CBF and cerebral autoregula-
tion	are	key	factors	to	improve	patient	outcome.	When	it	comes	
to TBI, literature in the field of moderate/severe TBI has dem-
onstrated that impaired cerebral autoregulation/cerebrovascu-
lar	 reactivity	 is	 directly	 associated	 with	 poor	 6-month	 global	
outcome.6,104,106,109,110 This has been validated in prospective 
multicenter data,106 and recent retrospective data sets suggest 
that cerebrovascular reactivity remains unaffected by changes 
in	 guideline-based	 management	 of	 TBI	 over	 the	 last	 25	 years,	
in concert with relatively stable mortality rates.105 Such find-
ings suggest that despite improvement in ICP and CPP target-
ing, cerebrovascular reactivity remains resistant to current 
therapeutic measures in moderate/severe TBI care, and may be 
a main contributor to persistently high mortality rates despite 
advancements in therapeutic targeting. There currently ex-
ists limited literature on the impact of commonly administered 
therapies in TBI, such as NE, and their impact on cerebrovas-
cular reactivity, with most suggesting an unclear association.111 
Cerebrovascular reactivity monitoring is being adopted to direct 
personalized physiologic targets in TBI care, including optimal 
CPP targeting,10,13,112 with the expectation that such personal-
ized approaches based on cerebrovascular monitoring will be 
extrapolated to other neuropathological states.7,113-117 Such 
concepts are currently being explored in phase II clinical trials.13 
Thus,	knowledge	of	the	impact	of	commonly	administered	vaso-
active compounds, such as NE, on the cerebrovascular response 
is crucial if we are to truly move toward such personalized medi-
cine approaches. Future studies require controlled evaluation of 
the NE effect on cerebrovascular reactivity/CBF, in both large 
animal	and	humans.	Such	work	would	benefit	from	the	continu-
ous evaluation of cerebrovascular reactivity, through such meth-
ods as the pressure reactivity index (PRx), with other concurrent 
multimodal cerebral physiologic monitoring, such as brain tissue 
oxygen, parenchymal CBF monitoring, and cerebral microdialy-
sis.	 Such	 work	 would	 provide	 important	 insights	 into	 the	 true	
cerebrovascular and cerebral physiologic impacts of NE.
In addition to this evaluation of NE in TBI with advanced mul-
timodal monitoring of cerebrovascular response, further animal 
models	are	required.	As	seen	in	the	described	literature	body,	the	
presence of TBI or other acquired brain injury may lead to different 
CBF responses compared to healthy animals/humans. This suggests 
a potential role for the regional disparities in BBB integrity mitigat-
ing	the	cerebrovascular/CBF	response	to	NE.	Future	work	into	NE	
models with BBB disruption is required to provide insight into the 
impact of BBB integrity on NE effects. In parallel to this, the control 
mechanisms involved in cerebral autoregulation are multifaceted, 
and	are	likely	the	impact	of	individual	genetic	polymorphisms	in	hu-
mans.118,119	Future	work,	both	in	humans	and	genetically	controlled	
animal models may also shed insight into variances in cerebro-
vascular/CBF	 catecholamine	 responses.	 All	 such	work	mentioned	
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requires substantial coordination between multiple centers of ex-




The animal models indicate an increase in vasoconstriction with NE 
administration through the alpha receptor in vessels. There appeared 
to	be	a	dose-dependent	increase	in	CBF	with	NE	administration	in	
healthy and CPR animal models, which was also seen in one human 
study. However, there was no clear trend to describe the global and 
rCBF changes seen during the injection of NE in models with TBI, 
acquired brain injury, or within any other group of human patients. 
Further investigation into the impact of NE on cerebrovasculature in 
large animal models and humans is required.
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